Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.
Launched by ERASMUS MEDICAL CENTER · Aug 9, 2023
Trial Information
Current as of September 07, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people with Major Depressive Disorder (MDD) by using mobile technology. MDD is a serious mental health condition affecting many individuals around the world, leading to feelings of sadness and difficulties in daily life. The researchers are exploring whether mobile screening can effectively identify and help manage MDD symptoms, ultimately improving the quality of life for participants and reducing health disparities among different groups of people.
To be eligible for the trial, participants need to be at least 18 years old, live in Rotterdam Zuid, and have access to a smartphone or tablet. They must also be able to give their consent to participate. However, individuals currently receiving treatment from a psychologist or psychiatrist for depression are not eligible. If you join the trial, you can expect to engage with the mobile screening process, which aims to provide support and resources to help manage your mental health. The trial is not yet recruiting participants, but it represents an exciting opportunity to improve how we address depression using technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old Live in Rotterdam Zuid
- • Have access to a smartphone or tablet.
- • Give informed consent
- Exclusion Criteria:
- • - Is currently treated by a psychologist or psychiatrist for depressive symptoms
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, , Netherlands
Patients applied
Trial Officials
Inge de Kok, PhD
Principal Investigator
Erasmus Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported